Jeff L. Vacirca
Director · Caris Life Sciences, Inc.
IndividualBuying only
- 2026
- Aug 14, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeff L. Vacirca files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Baxley Spetzler - $14.84M in CAI purchases and sales in the last 12 months
- Brian J. Brille - $12.13M in CAI purchases and sales in the last 12 months
- Jon Halbert - $990K in CAI purchases and sales in the last 12 months
- John Russel Denton - $339K in CAI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeff L. Vacirca?
Jeff L. Vacirca is a corporate insider, tracked as Director of Caris Life Sciences, Inc. (CAI). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeff L. Vacirca submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jeff L. Vacirca been buying or selling stock?
Recorded transactions: 1 open-market purchase ($501K) and 0 open-market sales across all tracked filings.
